E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers M > Headlines for Molecular Devices Corp. > News item
Published on 3/15/2007 in the Prospect News Special Situations Daily.

Gabelli, Gamco increase stake in Molecular Devices

By Lisa Kerner

Charlotte, N.C., March 14 - A group of investors led by Gabelli Funds, LLC and Gamco Asset Management Inc. used $39,637,442 to purchase shares of Molecular Devices Corp. stock, according to a schedule 13D filing with the Securities and Exchange Commission.

Gabelli Funds beneficially own 489,680 shares, or 2.97%, and Gamco owns 200,888 , or 1.22%, of the Sunnyvale, Calif., medical device manufacturer's stock.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.